EBX-102

N/A

Report date: 2024/04/12 18:14:29

Base Information

Drug NameEBX-102
Drug Alias NameEBX-102
ClassificationBiologics > Live Biotherapeutic
Mechanisms of ActionGastrointestinal microbiome modulatorsBacteria replacements
TargetsNot applicable
Therapy Area/IndicationsMyelodysplastic SyndromesLiver CirrhosisHepatic Encephalopathy +[8
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEnteroBiotix Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMyelodysplastic SyndromesLiver CirrhosisHepatic Encephalopathy +[8
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A